Inventor · disambiguated record
Susan E. Bates
Also filed as: BATES SUSAN · BATES SUSAN E · BATES SUSAN ELAINE
12 granted patents·9 pending applications·29 citations·filing 1998–2024
85Inventor score
Top patents by PatentIndex Score
21 records- 0183US6521635B1Inhibition of MXR transport by acridine derivativesUS HEALTH·Filed 2001·Granted Feb 18, 2003·22 cites·14 claims
- 0271US9937217B2Method of inhibiting ABCG2 and related treatmentsUS HEALTH·Filed 2015·Granted Apr 10, 2018·1 cites·9 claims
- 0367US8470888B2Botryllamides and method of inhibiting PGP in a mammal afflicted with cancerHENRICH CURTIS J·Filed 2008·Granted Jun 25, 2013·0 cites·3 claims
- 0466US9114102B2Method of inhibiting ABCG2 and related treatmentsHENRICH CURTIS J·Filed 2008·Granted Aug 25, 2015·0 cites·12 claims
- 0565US9314448B2Method of inhibiting ABCG2 and other treatment methodsUS HEALTH·Filed 2013·Granted Apr 19, 2016·1 cites·15 claims
- 0660US2024335428A1Pateamine a derivative for treating pancreatic cancerUNIV BAYLOR·Filed 2024·Application pending·0 cites
- 0755US7989501B2Treating renal cancer using a 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehydeUS HEALTH·Filed 2005·Granted Aug 2, 2011·0 cites·27 claims
- 0855US2022251143A1Non-hydrolyzable non-cleavable, stable linkers for precision therapeutics and uses thereofUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 0953US2011015168A1Methods for increasing levels of human fetal hemoglobinKEEGAN MITCHELL·Filed 2007·Application pending·0 cites
- 1050US8957027B2Deacetylase inhibitor therapyMCCULLOCH WILLIAM·Filed 2007·Granted Feb 17, 2015·0 cites·22 claims
- 1150US2007048810A1ATP-binding cassette protein responsible for cytotoxin resistanceGOV OF U S A AS REPRESENTED BY·Filed 2006·Application pending·0 cites
- 1248US7138493B1ATP-binding cassette protein responsible for cytotoxin resistanceUS HEALTH·Filed 1999·Granted Nov 21, 2006·5 cites·4 claims
- 1346US2013123184A1Methods for increasing levels of human fetal hemoglobinKEEGAN MITCHELL·Filed 2012·Application pending·0 cites
- 1444US8273797B2Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehydeMERTINS SUSAN D·Filed 2011·Granted Sep 25, 2012·0 cites·20 claims
- 1544US2009325156A1Materials and methods for abcb1 polymorphic variant screening, diagnosis, and treatmentUS GOV HEALTH & HUMAN SERV·Filed 2006·Application pending·0 cites
- 1642US9259452B2Deacetylase inhibitor therapyCELGENE CORP·Filed 2015·Granted Feb 16, 2016·0 cites·40 claims
- 1741US8673888B2Depsipeptide for therapy of kidney cancerNAOE YOSHINORI·Filed 2003·Granted Mar 18, 2014·0 cites·6 claims
- 1839US2004132643A1Histone deacelylase inhibitors in diagnosis and treatment of thyroid neoplasmsFiled 2002·Application pending·0 cites
- 1937US2008292616A1Topical Formulations of Histone Deacetylase Inhibitors and Methods Using the SameUS GOV HEALTH & HUMAN SERV·Filed 2006·Application pending·0 cites
- 2035US2004259772A1Use of a histone deacetylase inhibitor to increase the entry of an adenoviral agent into a cellFiled 2002·Application pending·0 cites
- 2125USRE40839ETaxol treatment of cancerUS HEALTH·Filed 1998·Granted Jul 7, 2009·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →